Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

Drug-eluting stents above the knee.

¹Department of Angiology, Medical University Vienna, Austria. erich.minar@meduniwien.ac.at

The Journal of Cardiovascular Surgery

|April 5, 2011

Summary

Limited trials exist for drug-eluting stents (DES) in the femoropopliteal artery. Promising new data from the Zilver PTX stent suggest improved outcomes, but longer-term follow-up is needed.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.

Journal of thrombosis and haemostasis : JTH·2016

Same author

Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology.

International angiology : a journal of the International Union of Angiology·2014

Same author

Latest developments in SFA management.

The Journal of cardiovascular surgery·2014

Same author

Femoral stenting: what do the guidelines tell us.

The Journal of cardiovascular surgery·2013

Same author

Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions.

The Journal of cardiovascular surgery·2012

Same author

Superficial vein thrombosis: a consensus statement.

International angiology : a journal of the International Union of Angiology·2012

Area of Science:

Vascular Surgery
Interventional Cardiology
Biomaterials Science

Background:

Few clinical trials have investigated drug-eluting stents (DES) for femoropopliteal artery disease.
Previous DES trials in this segment showed no significant mid-term patency improvement over bare-metal stents.
Recent unpublished data on the Zilver PTX stent (paclitaxel-eluting) show promising results.

Purpose of the Study:

To evaluate the efficacy and safety of drug-eluting stents in the femoropopliteal segment.
To compare the performance of novel DES against traditional bare-metal stents.
To assess the potential of polymer-free drug-coated stents for improved vascular outcomes.

Main Methods:

Review of existing clinical trials and recently presented data on femoropopliteal stenting.
Analysis of outcomes including mid-term patency rates.
Focus on sirolimus-eluting, everolimus-eluting, and paclitaxel-eluting stents.

Main Results:

Earlier DES trials did not demonstrate superior mid-term patency compared to bare-metal stents.
The Zilver PTX stent, a polymer-free paclitaxel-coated stent, has shown very promising, albeit unpublished, results.
Further long-term follow-up data are required for definitive conclusions.

Conclusions:

The Zilver PTX stent shows potential for improved femoropopliteal artery treatment.
Longer-term data are crucial to validate the efficacy of this new stent technology.
Future developments may include bioabsorbable DES to mitigate risks associated with permanent implants.

Related Experiment Videos

Last Updated: Jun 3, 2026

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023